
Nilotinib (200mg)
Active composition
Nilotinib inhibits BCR-ABL tyrosine kinase activity, blocking the signaling pathways that promote cancer cell growth.
Medical applications
The Nilocap 200mg Capsule contains Nilotinib, a potent tyrosine kinase inhibitor. Indicated for chronic myeloid leukemia (CML) in chronic, accelerated, or blast phase, including those with the Philadelphia chromosome (Ph+) in the absence of an approved TKI or in cases of intolerance or resistance to prior TKIs. Nilocap should be taken orally, twice daily, approximately 12 hours apart, with a light meal. Patients should be monitored closely for adverse effects such as fluid retention, pleural effusion, QTc interval prolongation, and hepatotoxicity. Dose adjustments may be necessary based on individual patient response and tolerability. Avoid concomitant administration with strong CYP3A4 inhibitors and inducers. It is crucial to maintain a comprehensive drug monitoring program throughout therapy.
Aminopyrimidine Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nilocap 200mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nilocap 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Nilocap 200mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nilocap 200mg Capsule may not be needed in these patients. Please consult your doctor.
Exercise Caution
Nilocap 200mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nilocap 200mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Nilocap 200mg Capsule may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Nilocap 200mg Capsule

Nilotinib (200mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Nilotinib inhibits BCR-ABL tyrosine kinase activity, blocking the signaling pathways that promote cancer cell growth.
Medical applications
The Nilocap 200mg Capsule contains Nilotinib, a potent tyrosine kinase inhibitor. Indicated for chronic myeloid leukemia (CML) in chronic, accelerated, or blast phase, including those with the Philadelphia chromosome (Ph+) in the absence of an approved TKI or in cases of intolerance or resistance to prior TKIs. Nilocap should be taken orally, twice daily, approximately 12 hours apart, with a light meal. Patients should be monitored closely for adverse effects such as fluid retention, pleural effusion, QTc interval prolongation, and hepatotoxicity. Dose adjustments may be necessary based on individual patient response and tolerability. Avoid concomitant administration with strong CYP3A4 inhibitors and inducers. It is crucial to maintain a comprehensive drug monitoring program throughout therapy.
Aminopyrimidine Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nilocap 200mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nilocap 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Nilocap 200mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nilocap 200mg Capsule may not be needed in these patients. Please consult your doctor.
Exercise Caution
Nilocap 200mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nilocap 200mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Nilocap 200mg Capsule may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Nilocap 200mg Capsule















